(Q34346741)

1 August 2017

1 reference

title

Mycophenolate mofetil: implications for the treatment of glomerular disease (English)

1 reference

1 August 2017

C Badid

1

1 reference

1 August 2017

A Desmouliere

series ordinal

2

1 reference

1 August 2017

M Laville

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Nephrology Dialysis Transplantation

1 August 2017

published in

1 reference

1 August 2017

volume

16

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

1752-1756

1 reference

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Use of mycophenolate mofetil in resistant membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil can prevent the development of diabetes in BB rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Suppression of the humoral immune response by mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Biopsy-proven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Successful mycophenolate mofetil treatment of glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.9.1752

21 January 2018

Identifiers

DOI

10.1093/NDT/16.9.1752

1 reference

1 August 2017

1 reference